发明名称 Novel cyclic amide derivatives
摘要 Describes compounds represented by the formula (I) or a salt thereof, or a hydrate or a solvate thereof: wherein: X represents alkyl, cycloalkyl-substituted alkyl, aryl-substituted alkyl, aryl-substituted alkenyl, aryl-substituted alkynyl, monocyclic or polycyclic cycloalkyl which may be substituted with an alkyl, aryl, heterocyclic group, or substituted or unsubstituted amino group; Q represents a group represented by -CH2-, -CO-, -O-, -S-, -CH(OR7)-, -C(=CH2)- or -(=NR8)- wherein R represents a hydrogen, alkyl, hydroxyalkyl, or an acyl group, and R8 represents a hydroxyl, alkoxyl, aralkyloxy, acyloxy, acylamino, or an alkoxycarbonyl amino group; n represents an integer of from 0 to 5; R1 and R2 each independently represent a hydrogen atom or an alkyl group, or R1 and R2 combine to form an alkylene group; B represents either of the groups defined in formula (II): Further describes the use of the compounds of formula (I) in the manufacture of a medicament, which is used for a disease that can be therapeutically and/or preventatively treated by nerve controlling function of a sigma ligand, in a patient in need thereof.
申请公布号 NZ521576(A) 申请公布日期 2005.06.24
申请号 NZ20010521576 申请日期 2001.02.26
申请人 MITSUBISHI PHARMA CORPORATION 发明人 YAMABE, HARUKO;OKUYAMA, MASAHIRO;NAKAO, AKIRA;OOIZUMI, MITSURU;SAITO, KEN-ICHI
分类号 A61K31/454;A61K31/4709;A61K31/4725;A61P1/04;A61P1/06;A61P9/06;A61P9/10;A61P9/12;A61P25/00;A61P35/00;A61P43/00;C07D401/06;C07D401/14;C07D405/14;C07D409/14;C07D413/14;C07D471/04;C07D491/04;C07D491/048;C07D495/04;(IPC1-7):C07D401/06;A61K31/470;A61K31/472 主分类号 A61K31/454
代理机构 代理人
主权项
地址